Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group

M. Joerger; A.D.R. Huitema; D.J. Richel; C. Dittrich; N. Pavlidis; E. Briasoulis; J.B. Vermorken; E. Strocchi; A. Martoni; R. Sorio; H.P. Sleeboom; M.A. Izquierdo; D.I. Jodrell; H. Calvert; A. Boddy; H. Hollema; R. Féty; W.J.F. van der Vijgh; G. Hempel; E. Chatelut; M. Karlsson; J. wilkins; B. Tranchand; A.H. Schrijvers; C. Twelves; J.H. Beijnen; J.H.M. Schellens

Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group

M. Joerger
, A.D.R. Huitema
, D.J. Richel
, C. Dittrich
, N. Pavlidis
, E. Briasoulis
, J.B. Vermorken
, E. Strocchi
, A. Martoni
, R. Sorio
, H.P. Sleeboom
, M.A. Izquierdo
, D.I. Jodrell
, H. Calvert
, A. Boddy
, H. Hollema
, R. Féty
, W.J.F. van der Vijgh
, G. Hempel
, E. Chatelut

M. Karlsson, J. wilkins, B. Tranchand, A.H. Schrijvers, C. Twelves, J.H. Beijnen, J.H.M. Schellens

Dept of Pharmaceutical Sciences

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	6410-6418
Number of pages	9
Journal	British Journal of Clinical Pharmacology
Volume	13
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Joerger, M., Huitema, A. D. R., Richel, D. J., Dittrich, C., Pavlidis, N., Briasoulis, E., Vermorken, J. B., Strocchi, E., Martoni, A., Sorio, R., Sleeboom, H. P., Izquierdo, M. A., Jodrell, D. I., Calvert, H., Boddy, A., Hollema, H., Féty, R., van der Vijgh, W. J. F., Hempel, G., ... Schellens, J. H. M. (2007). Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. British Journal of Clinical Pharmacology, 13, 6410-6418.

Joerger, M. ; Huitema, A.D.R. ; Richel, D.J. et al. / Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. In: British Journal of Clinical Pharmacology. 2007 ; Vol. 13. pp. 6410-6418.

@article{1a8b58e900654c2c94fb50e99b7174e0,

title = "Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group",

author = "M. Joerger and A.D.R. Huitema and D.J. Richel and C. Dittrich and N. Pavlidis and E. Briasoulis and J.B. Vermorken and E. Strocchi and A. Martoni and R. Sorio and H.P. Sleeboom and M.A. Izquierdo and D.I. Jodrell and H. Calvert and A. Boddy and H. Hollema and R. F{\'e}ty and \{van der Vijgh\}, W.J.F. and G. Hempel and E. Chatelut and M. Karlsson and J. wilkins and B. Tranchand and A.H. Schrijvers and C. Twelves and J.H. Beijnen and J.H.M. Schellens",

year = "2007",

language = "Undefined/Unknown",

volume = "13",

pages = "6410--6418",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

}

Joerger, M, Huitema, ADR, Richel, DJ, Dittrich, C, Pavlidis, N, Briasoulis, E, Vermorken, JB, Strocchi, E, Martoni, A, Sorio, R, Sleeboom, HP, Izquierdo, MA, Jodrell, DI, Calvert, H, Boddy, A, Hollema, H, Féty, R, van der Vijgh, WJF, Hempel, G, Chatelut, E, Karlsson, M, wilkins, J, Tranchand, B, Schrijvers, AH, Twelves, C, Beijnen, JH & Schellens, JHM 2007, 'Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group', British Journal of Clinical Pharmacology, vol. 13, pp. 6410-6418.

Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. / Joerger, M.; Huitema, A.D.R.; Richel, D.J. et al.
In: British Journal of Clinical Pharmacology, Vol. 13, 2007, p. 6410-6418.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group

AU - Joerger, M.

AU - Huitema, A.D.R.

AU - Richel, D.J.

AU - Dittrich, C.

AU - Pavlidis, N.

AU - Briasoulis, E.

AU - Vermorken, J.B.

AU - Strocchi, E.

AU - Martoni, A.

AU - Sorio, R.

AU - Sleeboom, H.P.

AU - Izquierdo, M.A.

AU - Jodrell, D.I.

AU - Calvert, H.

AU - Boddy, A.

AU - Hollema, H.

AU - Féty, R.

AU - van der Vijgh, W.J.F.

AU - Hempel, G.

AU - Chatelut, E.

AU - Karlsson, M.

AU - wilkins, J.

AU - Tranchand, B.

AU - Schrijvers, A.H.

AU - Twelves, C.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

PY - 2007

Y1 - 2007

M3 - Article

SN - 0306-5251

VL - 13

SP - 6410

EP - 6418

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

ER -

Joerger M, Huitema ADR, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E et al. Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. British Journal of Clinical Pharmacology. 2007;13:6410-6418.